Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.
about
Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature reviewCost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisalMonitoring HIV viral load in resource limited settings: still a matter of debate?Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapyThe increasing chronicity of HIV in sub-Saharan Africa: Re-thinking "HIV as a long-wave event" in the era of widespread access to ARTThe effect of tuberculosis on mortality in HIV positive people: a meta-analysis.Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic reviewPredictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania.Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.Antiretroviral therapy, labor productivity, and sex: a longitudinal cohort study of tea pluckers in Kenya.First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaborationMeasures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.The study of HIV and antenatal care integration in pregnancy in Kenya: design, methods, and baseline results of a cluster-randomized controlled trialQuality of life of Nigerians living with human immunodeficiency virus.Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.Quality of life, psychosocial health, and antiretroviral therapy among HIV-positive women in Zimbabwe.Combination Antiretroviral Therapy for HIV in Rwandan Adults: Clinical Outcomes and Impact on Reproductive Health up to 24 Months.Hearing Loss in HIV-Infected Children in Lilongwe, Malawi.Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa.Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settingsImpact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in MozambiqueImpact of prior HAART use on clinical outcomes in a large Kenyan HIV treatment program.Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso.Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon.Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings.Ensuring quality of care in the scale-up of HIV care and treatment in resource-limited settings: a challenge for all
P2860
Q22248034-209DFE87-8E41-459A-B9C0-3AD1C151BBC0Q28476337-5BFDB4F3-4D2E-4385-9CF7-E56A858A9308Q28485511-242ACD63-87F3-46D5-9768-C7219018ACC8Q30395110-B7C0053D-221A-4811-809A-0CA06965956FQ30408451-C10E20FA-53E0-478B-B723-0DFF4BB6B772Q30994512-35ACD366-8CED-43ED-9546-400F81D06F1BQ33302944-C4940D90-02DD-4B7D-B8C9-027B29A18F1CQ33330114-72B939AC-8747-466E-8EAA-61A8F657E719Q33459535-A8B3497E-693D-4B57-8E73-793204DD32B0Q33831891-89A9D3B0-B99A-4FF5-B4B3-87EF136FCC20Q33891896-5C94BD80-87EC-4782-B145-DDDFEF563B76Q34040080-D5523351-7541-411B-BDB4-A6C9AAF86E94Q34395892-79FB9163-434A-420E-BFE5-AE15796006F7Q34412260-71C3A916-13CF-4C1B-8455-E645249F22A2Q34563986-980F11F7-148D-43DC-A96F-0ED7BD4F6EE5Q34732899-D6941771-AA31-4F8B-9985-71F5EEC111CEQ35606036-7D3D2248-492C-4156-81DA-ED78C1FD25A7Q35901466-80E12675-48C6-4352-B8D8-0D2B11F814CDQ36110248-A93592F8-2E94-4B6D-AAAF-24C65F38DCD6Q36325668-DC43E295-77F7-4CDA-A17E-AA4FC4DDFD50Q36417372-7968D65D-7FF4-47ED-A240-422DD711D405Q37003942-9AFCF925-47B0-4798-BBD3-E2910F7EAFD5Q37127890-FDD51F74-6CCF-49B0-AB51-64C90A83238FQ37327770-B925465E-D258-46F7-9930-3ACFE923707FQ37411769-BECAA7D0-0DA5-4E6B-8BBE-0F9017DB2374Q37477423-818E5B79-EFAD-41E6-9F29-2DE4E3AF62C5Q37579676-FB26F733-AE81-4403-855F-9AC8AD5FC2E8Q37590039-2DFCEEE9-6750-4141-A64E-A0D8B513B406Q58232379-9A64FE28-2F06-4362-A07B-C0AE708059A2
P2860
Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Implementation of an antiretro ...... ults from 4 African countries.
@en
type
label
Implementation of an antiretro ...... ults from 4 African countries.
@en
prefLabel
Implementation of an antiretro ...... ults from 4 African countries.
@en
P2093
P1476
Implementation of an antiretro ...... ults from 4 African countries.
@en
P2093
Cissy Kityo
Cohort Program to Evaluate Access to Antiretroviral Therapy and Education Project Team
Emmanuel Bissagnene
Esther Waalberg
Ferdinand W N M Wit
Joep M Lange
Leander F Otieno
Papa S Sow
Philippe Clevenbergh
Ruurd Bennink
P304
P356
10.1097/QAI.0B013E31802BF109
P407
P577
2007-03-01T00:00:00Z